BIOSPECIFICS TECHNOLOGIES CORP Debt Securities, Held-to-maturity, Noncurrent
BIOSPECIFICS TECHNOLOGIES CORP had Debt Securities, Held-to-maturity, Noncurrent of $34.32 million as of 2020-09-30, per its 10-Q filed 2020-11-09.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Long-Term Investments
us-gaap:HeldToMaturitySecuritiesNoncurrent · last filed 2020-11-09
- 2020-09-30: Debt Securities, Held-to-maturity, Noncurrent $34.32M.
- 2020-06-30: Debt Securities, Held-to-maturity, Noncurrent $20.79M.
- 2020-03-31: Debt Securities, Held-to-maturity, Noncurrent $9.39M.
- 2019-12-31: Debt Securities, Held-to-maturity, Noncurrent $16.57M.
| Period end | Debt Securities, Held-to-maturity, Noncurrent |
|---|---|
| 2020-09-30 | $34.32M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $20.79M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $9.39M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $16.57M 10-Q · filed 2020-11-09 |
| 2019-09-30 | $16.49M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $8.23M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $3.64M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $1.10M 10-K · filed 2020-03-16 |
| 2018-09-30 | $5.17M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $7.16M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $2.84M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $5.75M 10-K · filed 2019-04-02 |
| 2017-09-30 | $6.72M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $7.40M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $8.10M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $3.77M 10-K · filed 2018-03-14 |
| 2016-09-30 | $1.44M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $2.26M 10-Q · filed 2016-08-09 |
| 2015-12-31 | $3.60M 10-K · filed 2017-03-16 |
| 2014-12-31 | $1.25M 10-K · filed 2016-03-14 |
| 2013-12-31 | $0.00 10-K · filed 2015-03-16 |